CYFRA 21-1 predicts efficacy of combined chemoimmunotherapy in patients with advanced non-small cell lung cancer: a prospective observational study.

Nobutaka KataokaYuki KatayamaTadaaki YamadaKenji MorimotoTakayuki TakedaAsuka OkadaShinsuke ShiotsuYusuke ChiharaOsamu HiranumaTakahiro YamadaTakahiro OtaTaishi HaradaIsao HasegawaNaoya NishiokaMasahiro IwasakuShinsaku TokudaKoichi Takayama

Published in: Translational lung cancer research (2024)

After combined chemoimmunotherapy treatment, serum CYFRA 21-1 stands out as a potentially valuable biomarker for predicting the prognosis of NSCLC.

Keyphrases

advanced non small cell lung cancer
epidermal growth factor receptor
small cell lung cancer
tyrosine kinase